GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Stock Based Compensation

VGI Health Technology (XNEC:VTL) Stock Based Compensation : A$0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Stock Based Compensation?

VGI Health Technology's Stock Based Compensation for the six months ended in . 20 was A$0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.


VGI Health Technology Stock Based Compensation Historical Data

The historical data trend for VGI Health Technology's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Stock Based Compensation Chart

VGI Health Technology Annual Data
Trend
Stock Based Compensation

VGI Health Technology Semi-Annual Data
Stock Based Compensation

VGI Health Technology Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.


VGI Health Technology Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines